Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Castro (Lisbon, Portugal), G. Lockett (Southampton, United Kingdom), . Lau (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), E. Scott (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), A. Chauhan (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom), J. Holloway (Southampton, United Kingdom). Ykl-40 and phenotyping of severe asthma. 4084

Member's Comments

No comment yet.

Related content which might interest you: Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Lipidomic phenotyping of severe asthma Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Improved definition of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 The management of mild asthma Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020 Year: 2021 Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Difficult-to-treat and severe asthma Source: Breathe 2014; 10: 91-94 Year: 2014 Immunotherapy in severe asthma Source: ERS webinar 2021: Immunotherapy in severe asthma Year: 2021 The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Phenotypes and endotypes of severe asthma Source: Annual Congress 2012 - PG14 From phenotypes to endotypes of asthma and COPD Year: 2012 The need for asthma phenotyping Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018 The need for asthma phenotyping Source: International Congress 2017 – PG15 Asthma stratification Year: 2017